<?xml version="1.0" encoding="UTF-8"?>
<p id="par0090">The spike protein S is the principal target of antibodies. The SARS-CoV monoclonal antibody CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient, was identified to bind potently with this protein [
 <xref rid="bib0440" ref-type="bibr">88</xref>]. This antibody may be a potential therapeutic candidate.
</p>
